Forstner, P.; Fuchs, L.; Luxner, J.; Grisold, A.; Steinmetz, I.; Dichtl, K.
Colistin, Meropenem–Vaborbactam, Imipenem–Relebactam, and Eravacycline Testing in Carbapenem-Resistant Gram-Negative Rods: A Comparative Evaluation of Broth Microdilution, Gradient Test, and VITEK 2. Antibiotics 2024, 13, 1062.
https://doi.org/10.3390/antibiotics13111062
AMA Style
Forstner P, Fuchs L, Luxner J, Grisold A, Steinmetz I, Dichtl K.
Colistin, Meropenem–Vaborbactam, Imipenem–Relebactam, and Eravacycline Testing in Carbapenem-Resistant Gram-Negative Rods: A Comparative Evaluation of Broth Microdilution, Gradient Test, and VITEK 2. Antibiotics. 2024; 13(11):1062.
https://doi.org/10.3390/antibiotics13111062
Chicago/Turabian Style
Forstner, Patrick, Lisa Fuchs, Josefa Luxner, Andrea Grisold, Ivo Steinmetz, and Karl Dichtl.
2024. "Colistin, Meropenem–Vaborbactam, Imipenem–Relebactam, and Eravacycline Testing in Carbapenem-Resistant Gram-Negative Rods: A Comparative Evaluation of Broth Microdilution, Gradient Test, and VITEK 2" Antibiotics 13, no. 11: 1062.
https://doi.org/10.3390/antibiotics13111062
APA Style
Forstner, P., Fuchs, L., Luxner, J., Grisold, A., Steinmetz, I., & Dichtl, K.
(2024). Colistin, Meropenem–Vaborbactam, Imipenem–Relebactam, and Eravacycline Testing in Carbapenem-Resistant Gram-Negative Rods: A Comparative Evaluation of Broth Microdilution, Gradient Test, and VITEK 2. Antibiotics, 13(11), 1062.
https://doi.org/10.3390/antibiotics13111062